(Q30716854)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

A review of safety-related pregnancy data surrounding the oral disease-modifying drugs for multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Ellen Lu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Bing Wei Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sura Alwan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Anne Synnes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Leanne Dahlgren

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

A Dessa Sadovnick

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

1 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

89-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24343726%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Current disease-modifying treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Multiple sclerosis and pregnancy: therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Multiple sclerosis and pregnancy: maternal considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Fingolimod: a novel immunosuppressant for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Dimethylfumarate is a potent inducer of apoptosis in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Randomized trial of oral teriflunomide for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Parenthood and immunomodulation in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-013-0131-5

Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720

21 January 2018

1 reference

12 December 2020

Insight into the mechanism of laquinimod action

1 reference

12 December 2020

Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration

1 reference

12 December 2020

Antiangiogenic effects of the quinoline-3-carboxamide linomide

1 reference

12 December 2020

Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis

1 reference

12 December 2020

FDA pregnancy risk categories and the CPS: do they help or are they a hindrance?

1 reference

12 December 2020

Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century

1 reference

12 December 2020